Vaccination with an Autologous Idiotype Based Vaccine Following a Chemotherapy Induced Remission Holds Promise in the Treatment of Patients with Follicular Lymphoma - a podcast by American Society of Clinical Oncology (ASCO)
from 2011-05-31T13:48:07
::
::
In this podcast, results of randomized phase III clinical trial evaluating the effects of a patient specific idiotype tumor vaccine in patients with follicular lymphoma are summarized. The results demonstrate that idiotype vaccination may improve disease free survival in patients with follicular lymphoma who achieve a remission following chemotherapy.
Further episodes of Journal of Clinical Oncology (JCO) Podcast
Further podcasts by American Society of Clinical Oncology (ASCO)
Website of American Society of Clinical Oncology (ASCO)